Amgen Awards The Bath Institute of Rheumatic Diseases $25,000 Through UPLIFT Innovation ChallengePRNewsWire • 11/17/21
LUMYKRAS® (sotorasib) Receives Positive Opinion From EMA CHMP For Patients With KRAS G12C-Mutated Advanced Non-Small Cell Lung CancerPRNewsWire • 11/12/21
3 Safe High-Yield Blue-Chips That Can Triple The Market's Returns In The Next 5 YearsSeeking Alpha • 11/10/21
First And Only Randomized, Double-blind, Head-to-head Study Comparing Aimovig® (erenumab-aooe), An Anti-CGRP Pathway Therapy, To Topiramate Published In CephalalgiaPRNewsWire • 11/08/21